Search the Newsreel

Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda

Keros Therapeutics, Inc. LEXINGTON, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of …

STAK Stock Whipsaws As Traders Focus On Volatile Breakout

STAK Inc. stock is exhibiting extreme volatility, having surged from $1 to over $12 and then pulling back, attracting momentum traders. The stock is currently consolidating within a tight range, suggesting a potential breakout. Despite modest fundamentals, the price action and high trading volume …

STAK Stock Slides Off Spike As Traders Watch Support

STAK Inc. stock has experienced a significant retracement after a rapid spike to an intraday high of $12, now trading around $2.78. This behavior is characteristic of a low-float squeeze followed by a fade, with traders monitoring key support and resistance levels. While the …

STAK Stock Pulls Back As Volatile Rally Cools

STAK Inc. experienced a significant rally followed by a sharp pullback, now consolidating between $2.50 and $2.85. The stock initially surged on news of an AI partnership expansion but has since unwound much of its gains, attracting active traders due to its high volatility. …

STAK|STAK|Price:2.640|Chg%:+0.210

This article provides real-time quotes, trading strategies, and related analysis for STAK (STAK Inc.), a holding company specializing in oilfield production and maintenance equipment. The stock experienced a significant -13.79% change today, although it has shown a +420.24% increase over the last six months. …

STAK Stock Whipsaws After Parabolic Spike, Volatility Draws Day Traders

STAK Inc. stock experienced a significant whipsaw effect, soaring from $1.23 to $12 before settling back into the $2-$3 range. This extreme volatility, driven by an AI platform partnership announcement, has attracted day traders who are now watching for consolidation between $2.60 and $3.05. …

STAK Stock Whipsaws As Traders Target High-Volatility Setup

STAK Inc. stock is exhibiting high volatility, swinging significantly from a $12 spike to the low $2s, making it a target for traders seeking sharp breakouts and breakdowns. Despite its rollercoaster price action, the company shows about $10M in working capital and a low …

Takeda Pharmaceutical Q1 Earnings Call Highlights

Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut Takeda Pharmaceutical (NYSE:TAK) said its first-quarter fiscal 2026 results were in line with its full-year outlook as growth from core brands and newer products largely offset expected declines in its mature portfolio. Revenue …

Earnings call transcript: Takeda Q1 2026 results show steady growth, stock slips premarket

Takeda Pharmaceutical reported Q1 2026 results indicating steady growth, with revenue reaching JPY 1.22 trillion, a 10.2% increase at actual exchange rates, though declining 0.5% at constant currency. Despite core EPS falling due to prior-year tax benefits, the company maintained its full-year guidance and …

Takeda Pharmaceutical (NYSE: TAK) Q1 2026 revenue ¥1.22T, EPS ¥71.65

Takeda Pharmaceutical Company Limited reported consolidated IFRS results for Q1 2026, with revenue reaching ¥1.22 trillion, a 10.2% year-on-year increase primarily due to Japanese yen depreciation. Despite increased revenue and operating profit, net profit attributable to owners declined by 8.9% to ¥113.2 billion, resulting …

Take-Two Interactive Software, Inc. $TTWO Shares Acquired by Amundi

Amundi increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 38.1% in the first quarter, now owning 1.35% of the company's stock valued at $492.56 million. Other institutional investors have also adjusted their holdings, while insiders have sold a significant amount of shares. Analysts …

Takeda Pharmaceutical Company Limited bestätigt Gewinnprognose für das Geschäftsjahr 2026

Takeda Pharmaceutical Co cuts FY26 adj EPS to $2.96, sales to $29.1B

Karnataka Bank Q4 Results: Unaudited financials released

Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Solid first quarter performance broadly in line with guidance, underpinned by resilient demand across core in-line brands Commercial execution and late-stage pipeline investments on schedule, including first approval for ORZEYFULTM (oveporexton) in China, setting the foundation for next wave of medicines No change to …

Should Take-Two’s Officer Liability Shield Proposal Reshape How TTWO Investors View Governance and Performance Risk?

At its September 17, 2026 Annual Meeting, Take-Two Interactive Software proposed amending its Restated Certificate of Incorporation to limit certain officers' liability in line with Delaware law, mainly shielding them from monetary damages in direct shareholder suits while retaining accountability for loyalty breaches and …

Karnataka discusses Takeda GCC expansion, innovation partnerships

Karnataka officials held discussions with Takeda Pharmaceutical leaders regarding the expansion of their Global Capability Centre (GCC) in Bengaluru. The talks focused on leveraging Karnataka's strong biotechnology and medtech ecosystems for digital transformation, research, and product development, including AI-driven drug discovery. Karnataka pledged continued …

Lazard Asset Management LLC Grows Stake in Take-Two Interactive Software, Inc. $TTWO

Lazard Asset Management LLC significantly increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 111.1% in the first quarter, now owning 213,026 shares valued at $42.1 million. Other institutional investors like Norges Bank and AQR Capital also expanded their positions, bringing institutional ownership to …

First Trust Advisors LP Buys 46,766 Shares of Take-Two Interactive Software, Inc. $TTWO

First Trust Advisors LP increased its stake in Take-Two Interactive Software, Inc. by 57.3% in the first quarter, purchasing an additional 46,766 shares to own a total of 128,452 shares valued at $25.37 million. This move is part of broader institutional investor activity, with …

Take Two Interactive Software (TTWO) Could Be 11% Undervalued After Officer Exculpation Proposal

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Take-Two Interactive Software (TTWO) has put a proposed Officer Exculpation Amendment on the agenda for its September 17, 2026 shareholder meeting, focusing on …

TTWO|Take-Two Interactive Software Inc|Price:247.570|Chg%:+3.620

This article provides a comprehensive stock analysis of Take-Two Interactive Software Inc (TTWO) by TradingKey, highlighting its healthy fundamentals, significant growth potential, and "fairly valued" status within the Software & IT Services industry. The stock has high institutional ownership and analyst ratings indicating a …

Karnataka Bank Q1 profit jumps 43% as asset quality improves

VAKIF MENKUL KIYMET YATIRIM ORTAKLIĞI A.Ş.(VKFYO) Özel Durum Açıklaması (Genel) 29 Temmuz 2026

Take Two Interactive Software (TTWO) Proposes Officer Liability Amendment For Shareholder Vote

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Take-Two Interactive Software (NasdaqGS:TTWO) has proposed an Officer Exculpation Amendment to its Restated Certificate of Incorporation. The amendment would limit the liability of certain officers to the …

Take-Two Interactive (TTWO) Laps the Stock Market: Here's Why

Take-Two Interactive (TTWO) saw a 1.5% increase in its stock price, outperforming the S&P 500's daily gain. Despite a recent monthly decline, the company is expected to report earnings on August 7, 2026, with revenue predicted to decrease year-over-year. Analysts' positive revisions and a …

Take-Two Interactive CLO Earned Nearly $8M Last Year

Take-Two Interactive's Chief Legal Officer maintained a compensation of nearly $8 million for the 2026 fiscal year, according to recent securities filings. This report from Law360 Pulse highlights the legal leader's steady earnings. The full article content is behind a paywall, requiring a free …

Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $19.2, Implies 10% Upside

Takeda Pharmaceutical Company Limited's average 12-month price target has been increased to $19.2, representing a potential 10% upside from its July 27 closing price. This revised target is based on estimates from 13 analysts, with forecasts ranging from $17.27 to $21.28 per share. The …

Is Take-Two (TTWO) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's …

SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target

SBI Securities initiated coverage on Takeda Pharmaceutical (4502.FU) with a Neutral rating and a price target of 5,400 yen. The Japanese pharmaceutical company's stock was trading at 5,744.00 JPY, down 0.43% for the day, as of the market close. The report from MT Newswires …

Take Two Interactive Software (TTWO) Seeks Shareholder Backing To Limit Officer Liability

Take-Two Interactive Software (TTWO) is proposing an amendment to its Certificate of Incorporation to limit certain officer liability, aligning with recent changes in Delaware corporate law. This "Officer Exculpation Amendment" would affect how direct shareholder claims are brought against executives, excluding breaches of loyalty …

STAK Stock Plunges As Traders Unwind Friday’s Massive 602% Rally

STAK Inc. shares plummeted over 62% in Monday trading, unwinding a significant 602% rally from the previous Friday. The decline appears to be primarily driven by profit-taking and a reversal of momentum, rather than new negative company-specific news. Despite strong momentum scores, the sharp …

Take-Two Interactive Software Inc (TTWO) Stock Up 5.3% but GF Va

Take-Two Interactive Software Inc (TTWO) stock rose 5.3% to $243.95, but GuruFocus's GF Value™ indicates it is 13.6% overvalued at $214.75. The stock has a GF Score™ of 77/100, suggesting above-average quality, yet insiders have sold $135.3 million worth of shares in the last …

Takeda (TSE:4502) Stock Looks Below Fair Value While Broader Checks Stay Mixed

Takeda Pharmaceutical stock has returned 91.4% over the past 5 years and appears undervalued on market multiples, yet broader valuation checks are mixed. The company's P/S ratio of 2.0x is below the model-based fair ratio of 3.4x, suggesting it's undervalued on sales despite recent …

Can Takeda Pharmaceutical (TSE:4502) Trade At A Discount On New Phase 3 Psoriasis Data?

Takeda Pharmaceutical (TSE:4502) has released positive Phase 3 data for its oral TYK2 inhibitor zasocitinib for plaque psoriasis, which has contributed to recent share price momentum. Despite this, the stock trades below analyst price targets and some intrinsic value estimates, suggesting it may be …

Take-Two Stock Guides to $8.2 Billion. GTA VI’s Launch Date Is Why.

Take-Two Interactive has projected fiscal 2027 net bookings to reach $8.0 billion to $8.2 billion, a 20% increase directly attributed to the confirmed November 19 launch of Grand Theft Auto VI. This guidance has led to a significant re-evaluation of Take-Two stock, with TIKR's …

(STAK) Institutional Confidence

The article provides an overview of institutional shareholding in STAK, detailing the number of shares held by various firms and any changes in their holdings. Key institutional investors include Lanying Capital Ltd, MT. Yang Holding Ltd, Citadel Advisors LLC, and XTX Markets LLC. The …